Please assess the completion status of the following clinical trial:

Trial Title: A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female aged 40 to 85 years with a clinical diagnosis of OA of the target knee according to the American College of Rheumatology (ACR) criteria, including:~* Symptoms for at least 6 months prior to screening, AND~* Knee pain in the target knee for 30 days of the preceding month (periarticular knee pain due to OA and not due to other conditions such as bursitis, tendonitis, etc.) AND~* The pain in the target knee required the use of nonsteroidal anti-inflammatory drugs (NSAIDs) either over the counter (OTC) per recommendation of a physician or prescribed.~Exclusion Criteria:~* Body mass index (BMI) \> 40~* Any subject who disobeyed the restriction of prohibited therapies (i.e., use rescue medication) during Screening Washout Period.~* Secondary OA of the knee (rheumatoid arthritis, gout, psoriasis, syphilitic neuropathy, ochronosis, metabolic or other primary bone disease or acute trauma).

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Diclofenac Sodium Active Topical Patch 1 (Type: EXPERIMENTAL): Diclofenac sodium 1 topical patches will be compared against placebo patches.
- Diclofenac Sodium Active Topical Patch 2 (Type: EXPERIMENTAL): Diclofenac sodium 2 topical patches will be compared against placebo patches.

Based on this trial design, predict the completion outcome and termination type (if applicable).